New Members to the BOPA Executive Committee

Please join us in welcoming the new roles for the coming year on the BOPA Executive Committee.

 

Change of Role:

Shereen Nabhani-Gebara will take over as Vice Chair as Emma Foreman steps down from the role.

New Executive Committee Members:

Michal Sladkowski – Co-Secretary Elect

Shumi Tattersfield – Co-Treasurer Elect

Alice Tew – Symposium and Immunotherapy Specialist Advisory Group Co-Chair

Clayton Wong – Co-Secretary Elect and Independent Sector Representative

 

 

Representations from Devolved Nations, Subcommittees and Co-Opted Roles:

 

Lorna Cairns – Northern Ireland Cancer Network (NICAN) Representative

Heather Dalrymple – Scottish Oncology Pharmacy Practice Group (SOPPG) Representative

Gail Povey – Wales Cancer Network SACT Medicines Management Subgroup Representative

 

Bastiaan Buijtenhuijs and Pinkie Chambers – Co-Chairs of the new AI Specialist Advisory Group

Melanie Dalby – Research Subcommittee Co-Chair

Claire Kennedy and Chandra Maraj – Pharmacy Technician Subcommittee Co-Chair (Until October)

 

Jackie Lewis – Community and Primary Care Pharmacy (CPCP) Subcommittee Co-Chair (Until October)

 

Lilia So – Equity, Diversity and Inclusion (EDI) Subcommittee Co-Chair

 

New to Oncology 1-Year Co-Opted Members:

Riona Browne

Uteng (Ivan) Lai

Supaluxan Paramanathan

Nilouphar Tejrar

Latest News

By BOPA Committee on 11th September 2024

BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course, 11 November 2024, Royal College of Physicians, London

This joint British Cardiovascular Society, British Cardio-Oncology Society and University College London Hospitals Cancer Academy course provides an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology.…

Read article
By BOPA Research Committee on 11th September 2024

Treatment delays and new evidence

Dear BOPA members We are delighted to share two studies that you may be interested in for your practices.  The studies outline the impact of treatment delays (i.e. Delays in…

Read article
By BOPA Research Committee on 9th September 2024

BOPA member publication on the impact of inter-cycle treatment delays on mortality in early-stage breast cancer

We would like to share a recent BOPA member publication Pinkie Chambers et al. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective…

Read article
By BOPA Research Committee on 9th September 2024

My Research Webinar: Understanding global participation in gynae-oncology RCTs: a systematic review approach

Wednesday 25th September 2024 13:00 GMT   Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered…

Read article